Hong Kong
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 25.60 B |
Jan. 27, 2025 | USD 17.19 | 2.12% |
|
Hong Kong |
|
2 |
USD 7.45 B |
Jan. 28, 2025 | USD 0.46 | 4.31% |
|
Hong Kong |
|
3 |
USD 6.58 B |
Jan. 27, 2025 | USD 0.38 | 2.08% |
|
Hong Kong |
|
4 |
USD 4.22 B |
Jan. 27, 2025 | USD 0.67 | 1.15% |
|
Hong Kong |
|
5 |
USD 2.69 B |
Jan. 28, 2025 | USD 1.48 | 0.68% |
|
Hong Kong |
|
6 |
USD 2.39 B |
Jan. 28, 2025 | USD 2.68 | -1.44% |
|
Hong Kong |
|
7 |
USD 2.18 B |
Jan. 27, 2025 | USD 0.93 | 2.39% |
|
Hong Kong |
|
8 |
USD 1.23 B |
Jan. 28, 2025 | USD 0.25 | -2.07% |
|
Hong Kong |
|
9 |
USD 1.20 B |
Jan. 27, 2025 | USD 0.41 | 0.30% |
|
Hong Kong |
|
10 |
USD 891.84 M |
Jan. 27, 2025 | USD 1.07 | 3.09% |
|
Hong Kong |
|
11 |
USD 514.34 M |
Jan. 27, 2025 | USD 0.80 | 2.57% |
|
Hong Kong |
|
12 |
USD 494.95 M |
Jan. 27, 2025 | USD 0.52 | 0.23% |
|
Hong Kong |
|
13 |
USD 433.14 M |
Jan. 27, 2025 | USD 0.22 | -1.18% |
|
Hong Kong |
|
14 |
USD 352.22 M |
Jan. 27, 2025 | USD 0.43 | -0.61% |
|
Hong Kong |
|
15 |
USD 351.89 M |
Jan. 27, 2025 | USD 0.44 | 1.16% |
|
Hong Kong |
|
16 |
USD 341.84 M |
Jan. 27, 2025 | USD 0.27 | 0.46% |
|
Hong Kong |
|
17 |
USD 231.11 M |
Jan. 27, 2025 | USD 0.15 | -0.02% |
|
Hong Kong |
|
18 |
USD 141.51 M |
Jan. 28, 2025 | USD 0.13 | -0.02% |
|
Hong Kong |
|
19 |
USD 104.25 M |
Jan. 28, 2025 | USD 0.19 | -0.02% |
|
Hong Kong |
|
20 |
USD 92.97 M |
Jan. 27, 2025 | USD 0.16 | -3.21% |
|
Hong Kong |
|
21 |
USD 64.14 M |
Jan. 31, 2025 | USD 5.25 | -2.96% |
|
Hong Kong |
|
22 |
USD 49.45 M |
Jan. 31, 2025 | USD 3.80 | 0.53% |
|
Hong Kong |
|
23 |
USD 38.70 M |
Jan. 28, 2025 | USD 0.37 | 4.31% |
|
Hong Kong |
The Healthcare company in Hong Kong with the highest Market Capitalization is BeiGene, Ltd. (HKSE: 6160.HK) at USD 25.60 B.
The Healthcare company in Hong Kong with the lowest Market Capitalization is Sirnaomics Ltd. (HKSE: 2257.HK) at USD 38.70 M.
The top 10 Healthcare companies in Hong Kong by Market Capitalization are BeiGene, Ltd., Alibaba Health Information Technology Limited, Sino Biopharmaceutical Limited, China Resources Pharmaceutical Group Limited, The United Laboratories International Holdings Limited, HUTCHMED (China) Limited, China Medical System Holdings Limited, China Traditional Chinese Medicine Holdings Co. Limited, SSY Group Limited and Beijing Tong Ren Tang Chinese Medicine Company Limited.
The bottom 10 Healthcare companies in Hong Kong by Market Capitalization are Sirnaomics Ltd., Regencell Bioscience Holdings Limited, Prenetics Global Limited, Lee's Pharmaceutical Holdings Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, SinoMab BioScience Limited, Dawnrays Pharmaceutical (Holdings) Limited, Perfect Medical Health Management Limited, OrbusNeich Medical Group Holdings Limited and Tycoon Group Holdings Limited.